AI Assistant
Blog
Pricing
Log In
Sign Up
927 Sparsentan for treatment of pediatric patients with selected proteinuric glomerular diseases: design of the phase 2 EPPIK study
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
